In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kipchu Tshering, Mir Misbahuddin
Format: Artigo
Idioma:Inglês
Publicat: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Col·lecció:Bangabandhu Sheikh Mujib Medical University Journal
Matèries:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Accés en línia:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars